Central Pharmaceutical Joint Stock Company No3 (HNX:DP3)

Market Cap	1.37T +21.0%
Revenue (ttm)	481.09B +18.6%
Net Income	164.47B +33.7%
EPS	7,650.02 +33.7%
Shares Out	21.50M
PE Ratio	8.30
Forward PE	n/a
Dividend	4,000.00 (6.30%)
Ex-Dividend Date	Mar 20, 2026

Volume	109,806
Open	63,000
Previous Close	63,500
Day's Range	62,700 - 63,500
52-Week Range	47,000 - 65,900
Beta	0.44
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 17, 2026

About HNX:DP3

Central Pharmaceutical Joint Stock Company No3 engages in the manufacturing and sale of pharmaceutical products primarily in Vietnam and internationally. The company offers medicines from medicinal herbs; pharmaceutical drugs; food that protects health products; and medical equipment; as well as cosmetics products. It is involved in the production and testing of drugs; growing spices and medicinal plants; production of functional foods; distilling and blending of spirits; production of non-alcoholic beverages and mineral water; and manufacturin...

• Industry: Pharmaceutical Preparations
• Founded: 1962
• Country: Vietnam
• Stock Exchange: Hanoi Stock Exchange
• Ticker Symbol: DP3

Financial Performance

In 2025, HNX:DP3's revenue was 438.01 billion, an increase of 4.92% compared to the previous year's 417.49 billion. Earnings were 153.56 billion, an increase of 26.73%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 4, 2026

Data Sources Report a data error